跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial - TGA Drug Approval Details
Approvals
/
TGA
/
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Approved
STANDARD
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Merz Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e404f3964c91c5ff
Company
Merz Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e404f3964c91c5ff
Product Name
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Artg Id
205507
Artg Name
XEOMIN, incobotulinumtoxinA, 50 units; purified neurotoxin, free from complexing proteins, Powder for solution for injection Vial
Sponsor
Merz Australia Pty Ltd
Company Detail Path
/organization/merz-australia-pty-ltd
Artg Date
2014-03-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ebdddc12478f70d88c242edaa9f8846b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/46a00ce9a501375df4b7c8ee6281ca63.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e404f3964c91c5ff
Type
Standard
Back to TGA Approvals